ArticleMolecular psychiatry2016
Common alleles contribute to schizophrenia in CNV carriers.
Article in Molecular psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Developmentally dynamic, non-convergent transcriptomic profiles in CNV models for schizophrenia risk.Molecular psychiatry · 2026Article
- Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells.Schizophrenia research · 2024Review
- Mechanisms of copy number variants in neuropsychiatric disorders: From genes to therapeutics.Current opinion in neurobiology · 2023Review
- Genomic findings in schizophrenia and their implications.Molecular psychiatry · 2023Review
- Loss of function of OTUD7A in the schizophrenia- associated 15q13.3 deletion impairs synapse development and function in human neurons.American journal of human genetics · 2022Article
- All for one and one for all: heterogeneity of genetic etiologies in neurodevelopmental psychiatric disorders.Current opinion in genetics & development · 2021Review
- The psychiatric phenotypes of 1q21 distal deletion and duplication.Translational psychiatry · 2021Article
- CRISPR-based functional evaluation of schizophrenia risk variants.Schizophrenia research · 2020Article
- Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells.Advances in neurobiology · 2020Review
- Quantifying the polygenic contribution to variable expressivity in eleven rare genetic disorders.Nature communications · 2019Article
- Synergistic effects of common schizophrenia risk variants.Nature genetics · 2019Article
- Generation of Isogenic Controls for In Vitro Disease Modelling of X-Chromosomal Disorders.Stem cell reviews and reports · 2019Article
- Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond.Frontiers in pharmacology · 2019Review
- The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases.Frontiers in molecular neuroscience · 2019Review
- Joint Contributions of Rare Copy Number Variants and Common SNPs to Risk for Schizophrenia.The American journal of psychiatry · 2019Article
- New considerations for hiPSC-based models of neuropsychiatric disorders.Molecular psychiatry · 2019Review
- Prospects for using risk scores in polygenic medicine.Genome medicine · 2017Article
- Using Induced Pluripotent Stem Cells to Investigate Complex Genetic Psychiatric Disorders.Current behavioral neuroscience reports · 2016Article
- Article
Corrections and comments
- Erratum for
Authors and funding
12 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.